Reviewer Board
Members of the reviewer board are selected from all Cancers reviewers for regularly providing timely high quality reports on submitted manuscripts. Responsibilities of reviewers are available here.
Members
Interests: nucleic acids; oxidative DNA damage; Purine 5′; 8-cyclo-2′-deoxynucleosides; enzymatic repair system; biomarkers discovery
Interests: brain tumors; pediatric oncology; cancer predisposition syndrome; high grade glioma; Medulloblastoma; midline glioma; Low grade glioma; ependymoma; Rhabdoid Tumors; cns germinoma
Interests: immunotherapy; cell-based therapies; immuno-oncology; immunometabolism; tumor microenvironment; anti-tumor immunity; Immunology
Interests: biostatistics; prevention; risk factors; epigenetics; DNA methylation; diet; cardiovascular risk; epicardial adipose tissue; intima media thickness; epidemiology; public health
Interests: JAK/STAT signalling; hematopoietic stem cells; hematopoietic malignancies; cancer cell signalling
Interests: cancer stem cells; EMT; breast cancer; differentiation therapy; 3D cell culture; personalized medicine; chemoresistance
Interests: CT and MR imaging of pancreatic and hepatic cancers
Interests: cancer biology; molecular biology; cell biology; liquid biopsy; optical spectroscopy; analytical chemistry; machine learning and data mining
Interests: Mesothelioma, cancers, signaling pathways, tumor microenvironment, biomarkers, liquid biopsy
Interests: breast cancer; gene regulation; tumor-initiating cells; tumor metabolism; chemoresistance; epigenetics; chromatin modifiers
Interests: lung cancer; thymic diseases; in particular tets; mesothelioma; lung metastasis
Interests: hypoxia; hypoxia-inducible factors (HIFs); hypoxia signaling pathway; cancer biology; reactive oxygen species (ros); oxidative stress; deubiquitinating enzymes (DUBs, USPs); er stress
2. INRIA Project Team Monc, IMB, UMR CNRS 5251, University of Bordeaux, 33400 Talence, France
Interests: multiple myeloma; PET/CT; lymphoma; radiomics; Artificial intelligence; dlbcl; Hodgkin’s lymphoma; nuclear medicine
Interests: genitourinary cancers; prostate; renal; cell carcinoma; urothelial carcinoma; germ cell tumours
Interests: radiomics; functional imaging; MRI
Interests: principal fields of research; pediatrics; neurology; lifestyles and nutrition; trial in the oncology field; trial in the urological field
Interests: neuro oncology; immunobiology of brain tumors; engineered immune cell therapies; synthetic biology; CAR T-based therapies
Interests: Gynecologic Cancer; Stromal-epithelial interaction; Hormonal effects on Cancers; signal transduction
Interests: oncology
Interests: epigenetics; DNA replication; gene expression; Signaling Pathways; cancer
Interests: colon cancer; cancer health disparity; Host-directed therapeutic and preventive modality using natural agents
Interests: radio-induced immune response; radiation therapy and Immunotherapy combination optimization; Radiation and nanoparticles combination
Interests: DNA DSB repair; DNA replication; Cell cycle checkpoints
Interests: survival analysis; treatment efficacy; toxicity risk; DNA repair; inflammation; Signaling Pathways; targeted therapies; single nucleotide polymorphism; miRNA; LncRNA; gene expression
Interests: cancer prevention; Inflammation; drug development; chemoprevention; animal models; molecular targets; immunoprevention; cancer stem cells
Interests: acute myeloid leukemia; Chronic Myeloid Leukemia; myelodisplastic syndromes
Interests: translational research; genitourinary tumors; neuroendocrine tumors; Kidney cancer; bladder cancer; prostate cancer; thyroid cancer; Clinical Research
Interests: non small cell lung cancer; immunotherapy; cancer immunology; tumor microenvironment; NSCLC mutations; targeted agents; thymoma; thymic carcinoma; small cell lung cancer
Interests: quantum dynamics; quantum chemistry and computational methods applied to cancer research; ion cancer therapy
Interests: growth factor/steroid hormone cross-talk in hormone-dependent tumors; growth factors signaling proteins as markers of breast cancerprogression; role of Forkhead Box transcription factor 3a (FoxO3a) in thetumorigenesis and progression of breast cancer; mechanisms of resistance to endocrine therapy in breast cancer; multifunctional mesoporous silica nanoparticles as innovative devices for targeted therapy